Compare ClearPoint Neuro Inc (CLPT) vs NICE Ltd (NICE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ClearPoint Neuro Inc vs NICE Ltd — how do they compare? ClearPoint Neuro Inc trades at $15.2 (market cap $454.21M), while NICE Ltd trades at $98.57 (market cap $6.02B). The key difference: NICE Ltd is far larger — about 13.3× ClearPoint Neuro Inc's market cap. Which is the better fit depends on your goals.
| CLPT | NICE | |
|---|---|---|
Market Cap | $454.21M | $6.02B |
Sector | Health | Technology |
52-Week High | $29.60 | $153.44 |
52-Week Low | $8.66 | $83.15 |
Enterprise Value | $488.79M | $5.75B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $15.18, up 4.19% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue growth but missed earnings expectations with a $0.38 loss per share. Despite negative profitability metrics, analyst consensus remains unanimously bullish with 100% buy ratings. Recent news highlights regulatory progress with partners and expansion of the drug delivery ecosystem.
The stock presents a high-risk opportunity with strong analyst support despite current losses. Investment thesis hinges on successful commercialization of neuro drug delivery technologies and partnership execution. Key risks include persistent negative cash flow from operations and delayed revenue ramp-up from new facilities. Upside depends on translating regulatory momentum into sustainable revenue growth.
NICE trades at $98.56, down 3.9% in the last session, with a bullish technical outlook supported by moving averages and a consensus price target of $115. The company reported Q2 2026 earnings beats, with revenue growth of 7.6% year-over-year, and maintains strong profitability margins. Recent news highlights partnerships with Currys and RingCentral to enhance AI-driven customer engagement solutions.
The stock presents a value opportunity with a P/E of 14.8 and positive earnings momentum, though risks include competitive pressures in the CX software space and a projected decline in net income for 2026. Analyst sentiment is predominantly bullish with no sell ratings, indicating confidence in near-term upside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →About NICE Ltd
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →
